0001493152-23-024750.txt : 20230717 0001493152-23-024750.hdr.sgml : 20230717 20230717170507 ACCESSION NUMBER: 0001493152-23-024750 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230713 FILED AS OF DATE: 20230717 DATE AS OF CHANGE: 20230717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elmaliah Oren CENTRAL INDEX KEY: 0001713701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37370 FILM NUMBER: 231092268 MAIL ADDRESS: STREET 1: 3 ARAVA ST., POB 1206 CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: My Size, Inc. CENTRAL INDEX KEY: 0001211805 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: HAYARDEN 4 CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 BUSINESS PHONE: 972-36009030 MAIL ADDRESS: STREET 1: HAYARDEN 4 CITY: AIRPORT CITY STATE: L3 ZIP: 7010000 FORMER COMPANY: FORMER CONFORMED NAME: Mysize Inc. DATE OF NAME CHANGE: 20150317 FORMER COMPANY: FORMER CONFORMED NAME: TOPSPIN MEDICAL INC DATE OF NAME CHANGE: 20021226 4 1 ownership.xml X0508 4 2023-07-13 0 0001211805 My Size, Inc. MYSZ 0001713701 Elmaliah Oren HAYARDEN 4 AIRPORT CITY L3 7010000 ISRAEL 1 0 0 0 0 Option to purchase Common Stock (right to buy) 26.00 2023-07-13 4 D 0 1200 D 2025-08-10 Common Stock, $.001 par value per share 1200 0 D Option to purchase Common Stock (right to buy) 1.09 2023-07-13 4 A 0 1200 A 2025-08-10 Common Stock, $.001 par value per share 1200 1200 D Option to purchase Common Stock (right to buy) 26.00 2023-07-13 4 D 0 40 D 2024-05-29 Common Stock, $.001 par value per share 40 0 D Option to purchase Common Stock (right to buy) 1.09 2023-07-13 4 A 0 40 A 2024-05-29 Common Stock, $.001 par value per share 40 40 D Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. On December 8, 2022, the Company implemented a 1-for-25 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split. /s/ Oren Elmaliah 2023-07-17